 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 4 | 1/1 | 返回列表 |
| 查看: 1394 | 回復: 3 | |||
zhangchong2303金蟲 (小有名氣)
|
[求助]
阿洛夫定（alovudine）新藥臨床幾期？
|
|
求助各位大俠，我想查詢一下阿洛夫定（alovudine）新藥臨床到幾期。一下我是美國的clinicaltrial上面查到的信息，看不懂是幾期怎么判斷。 Found 14 studies with search of: Alovudine Hide studies that are not seeking new volunteers. Hide studies with unknown recruitment status. Display Options Rank Status Study 1 Completed An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 2 Completed An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 3 Completed A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) Condition: HIV Infections Intervention: Drug: Alovudine 4 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3'-Deoxy-3'-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition: Neuroblastoma Intervention: Device: FLT-PET 5 Recruiting Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) Conditions: High-grade Glioma; Astrocytoma; Glioblastoma Intervention: Radiation: 18F Fluorothymidine PET CT 6 Recruiting Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors Condition: Breast Cancer Interventions: Drug: BMS-754807; Drug: letrozole 7 Recruiting A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Conditions: Cancer; Solid Tumor; Lymphoma Intervention: Biological: 18F-FLT 8 Recruiting Image-Guided Stereotactic Biopsy of High Grade Gliomas Conditions: Brain Cancer; Glioma Intervention: Procedure: 18F-FLT PET Scan 9 Completed 18F-FLT-PET in Breast Cancer (MK-0000-139 AM1) Condition: Breast Cancer Intervention: Procedure: 18F-FLT-Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging 10 Recruiting Pilot Study of 18F-FLT PET Conditions: CNS Brain Metastasis; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Esophageal Cancer Intervention: Procedure: Imaging with 18F-FLT PET 11 Terminated A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors Condition: Tumors of the Central Nervous System Intervention: Other: [18F]-Fluorothymidine 12 Recruiting An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine Condition: Pancreatic Cancer Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT 13 Recruiting Validation of 18F-MISO-PET and 18F-FLT-PET Condition: Head and Neck Neoplasms Intervention: Procedure: 18F-FLT and 18F-MISO-PET 14 Recruiting Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors Condition: Lung Cancer Intervention: 求解釋，非常感謝 |
回復此樓» 收錄本帖的淘帖專輯推薦
 新藥發(fā)現(xiàn) |
» 猜你喜歡
廣西醫(yī)科大學基礎醫(yī)學院自身免疫病課題組招收基礎醫(yī)學、藥學和生物學等專業(yè)的研究生
已經(jīng)有7人回復
-
[學習資料分享] FAERS數(shù)據(jù)庫的不良反應挖掘(頻數(shù)法/貝葉斯法)
已經(jīng)有1人回復
-
藥物學論文潤色/翻譯怎么收費?
已經(jīng)有191人回復
-
招收醫(yī)學、基礎醫(yī)學類調(diào)劑研究生
已經(jīng)有0人回復
-
是否屬于脾腎陽虛證
已經(jīng)有0人回復
-
腦梗怎么治療
已經(jīng)有3人回復
-
腦梗怎么治療
已經(jīng)有0人回復
-
生物組織中有目標分析物，專屬性怎么做
已經(jīng)有0人回復
-
廣西醫(yī)科大學基礎醫(yī)學院自身免疫病課題組招收基礎醫(yī)學相關專業(yè)的調(diào)劑研究生
已經(jīng)有2人回復
» 本主題相關價值貼推薦，對您同樣有幫助:
- Nat Biotech：2003-2011年新藥臨床研究成功率分析報告
已經(jīng)有6人回復
- 國外新藥，已經(jīng)進入Ⅱ期臨床研究的新藥進展情況如何查詢？？？
已經(jīng)有6人回復
- 中藥新藥臨床前研究藥學研究資料要注意什么才能提高通過率
已經(jīng)有3人回復
- 申報中藥新藥臨床批件到省局時的現(xiàn)場考核要注意什么？
已經(jīng)有4人回復
- 申請新藥臨床，已發(fā)批件，是否就是被批準臨床？
已經(jīng)有10人回復
- 三期臨床，真的很難
已經(jīng)有17人回復
- 【求助】請問新藥臨床試驗的申報資料在哪里可以查到啊？
已經(jīng)有7人回復
- 【求助】中藥新藥臨床研究指導原則第二輯 1993版
已經(jīng)有12人回復
- 【求助】新藥臨床前研究包括那些內(nèi)容
已經(jīng)有6人回復
nkbeholder
木蟲 (正式寫手)
- DRDEPI: 1
- 應助: 11 (小學生)
- 金幣: 2945.1
- 散金: 4
- 紅花: 5
- 帖子: 748
- 在線: 303.7小時
- 蟲號: 202353
- 注冊: 2006-03-01
- 性別: GG
- 專業(yè): 藥物化學
【答案】應助回帖
★
感謝參與，應助指數(shù) +1
lk590(金幣+1): 謝謝參與 2012-02-02 11:31:54
zhangchong2303(金幣+10): ★★★很有幫助 謝謝，從這上面看應該是臨床2期，是嗎？ 2012-02-02 13:47:37
感謝參與，應助指數(shù) +1
lk590(金幣+1): 謝謝參與 2012-02-02 11:31:54
zhangchong2303(金幣+10): ★★★很有幫助 謝謝，從這上面看應該是臨床2期，是嗎？ 2012-02-02 13:47:37
|
dialog上的信息，更新到2007年 Originator Company: Medivir AB (Sweden) Parent Company: Medivir AB Licensee: Beijing Mefuvir Medicinal Technology Highest Phase: Discontinued II Development Status: Discontinued II, France, HIV infections treatment Discontinued II, Sweden, HIV infections treatment Discontinued II, USA, HIV infections treatment |
2樓2012-02-02 11:28:31
nkbeholder
木蟲 (正式寫手)
- DRDEPI: 1
- 應助: 11 (小學生)
- 金幣: 2945.1
- 散金: 4
- 紅花: 5
- 帖子: 748
- 在線: 303.7小時
- 蟲號: 202353
- 注冊: 2006-03-01
- 性別: GG
- 專業(yè): 藥物化學
3樓2012-02-02 13:49:56
iamzane
至尊木蟲 (著名寫手)
- 應助: 129 (高中生)
- 貴賓: 0.7
- 金幣: 24628.1
- 散金: 40
- 紅花: 21
- 帖子: 1974
- 在線: 459.5小時
- 蟲號: 330866
- 注冊: 2007-03-24
- 專業(yè): 藥物學其他科學問題
4樓2012-02-02 13:53:25
相關版塊跳轉
我要訂閱樓主 zhangchong2303 的主題更新
| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0703化學調(diào)劑 +10 | 妮妮ninicgb 2026-03-15 | 14/700 |
|
|---|---|---|---|---|
|
[考研] 0817 化學工程 299分求調(diào)劑 有科研經(jīng)歷 有二區(qū)文章 +18 | rare12345 2026-03-18 | 18/900 |
|
|
|
[考研] 一志愿武漢理工材料工程專碩調(diào)劑 +5 | Doleres 2026-03-19 | 5/250 |
|
|
|
[考研] 0856調(diào)劑，是學校就去 +6 | sllhht 2026-03-19 | 7/350 |
|
|
|
[考博] 申博26年 +3 | 八6八68 2026-03-19 | 3/150 |
|
|
|
[考研] 266求調(diào)劑 +5 | 陽陽哇塞 2026-03-14 | 10/500 |
|
|
|
[考研] 一志愿天津大學化學工藝專業(yè)（081702）315分求調(diào)劑 +11 | yangfz 2026-03-17 | 11/550 |
|
|
|
[考研] 317求調(diào)劑 +3 | 申子申申 2026-03-19 | 6/300 |
|
|
|
[考研] 求調(diào)劑，一志愿:南京航空航天大學大學 ，080500材料科學與工程學碩，總分289分 +3 | @taotao 2026-03-19 | 3/150 |
|
|
|
[考研] 一志愿 西北大學 ，070300化學學碩，總分287，雙非一本，求調(diào)劑。 +3 | 晨昏線與星海 2026-03-19 | 3/150 |
|
|
|
[考研] 材料考研調(diào)劑 +3 | xwt。 2026-03-19 | 3/150 |
|
|
|
[考研] 0703化學 305求調(diào)劑 +4 | FY_yy 2026-03-14 | 4/200 |
|
|
|
[考研] 0854可跨調(diào)劑，一作一項核心論文五項專利，省、國級證書40+數(shù)一英一287 +8 | 小李0854 2026-03-16 | 8/400 |
|
|
|
[考研] 環(huán)境工程調(diào)劑 +8 | 大可digkids 2026-03-16 | 8/400 |
|
|
|
[考研] 有沒有道鐵/土木的想調(diào)劑南林，給自己招師弟中～ +3 | TqlXswl 2026-03-16 | 7/350 |
|
|
|
[考研] 考研調(diào)劑 +3 | 淇ya_~ 2026-03-17 | 5/250 |
|
|
|
[基金申請]
今年的國基金是打分制嗎？
 50+3
|
zhanghaozhu 2026-03-14 | 3/150 |
|
|
|
[考研] 318求調(diào)劑 +3 | Yanyali 2026-03-15 | 3/150 |
|
|
|
[考研] 294求調(diào)劑 +3 | Zys010410@ 2026-03-13 | 4/200 |
|
|
|
[考研] 招收0805（材料）調(diào)劑 +3 | 18595523086 2026-03-13 | 3/150 |
|